VIM and renal cell carcinoma: To confirm with proteomic expression, immunostaining for SMOC2 in patient- healthy margins and Stage 2-3 RCC tissue revealed a significant increase in SMOC2 protein in biopsies that were positive for the RCC mesenchymal marker vimentin and H&E staining of solid tumor growth (Fig. 1b).